» Articles » PMID: 31352585

Multimodal CT in Acute Stroke

Overview
Specialty Neurology
Date 2019 Jul 29
PMID 31352585
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Multimodal CT imaging (non-contrast CT, NCCT; CT angiography, CTA; and CT Perfusion, CTP) is central to acute ischemic stroke diagnosis and treatment. We reviewed the purpose and interpretation of each component of multimodal CT, as well as the evidence for use in routine care.

Recent Findings: Acute stroke thrombolysis can be administered immediately following NCCT in acute ischemic stroke patients assessed within 4.5 h of symptom onset. Definitive identification of a large vessel occlusion (LVO) requires vascular imaging, which is easily achieved with CTA. This is critical, as the standard of care for LVO within 6 h of onset is now endovascular thrombectomy (EVT). CTA source images can also be used to estimate the efficacy of collateral flow in LVO patients. The final component (CTP) permits a more accurate assessment of the extent of the ischemic penumbra. Complete multimodal CT, including objective penumbral measurement with CTP, has been used to extend the EVT window to 24 h. There is also randomized controlled trial evidence for extension of the IV thrombolysis window to 9 h with multimodal CT. Although there have been attempts to assess for responders to reperfusion strategies beyond 6 h ("late window") using collateral grades, the only evidence for treatment of this group of patients is based on selection using multimodal CT including CTP. The development of fully automated software providing quantitative ischemic penumbral and core volumes has facilitated the adoption of CTP and complete multimodal CT into routine clinical use. Multimodal CT is a powerful imaging algorithm that is central to current ischemic stroke patient care.

Citing Articles

AI-Based Automated Quantification of Arterial Stenosis in Head and Neck CT Angiography: A Comparison with Manual Measurements from Digital Subtraction Angiography and CT Angiography.

Huan X, Yang Y, Niu S, Yang Y, Tian B, Guo D Clin Neuroradiol. 2024; .

PMID: 39625680 DOI: 10.1007/s00062-024-01464-6.


Development, assessment and validation of a novel nomogram model for predicting stroke mimics in stroke center:A single-center observational study.

Chen X, Zhang S Heliyon. 2024; 10(19):e38602.

PMID: 39403531 PMC: 11472074. DOI: 10.1016/j.heliyon.2024.e38602.


Enhancing daily living and cognitive functions in traumatic brain injury patients through Orem's self-care theory.

Sha P, Gao X, Yu R, Li Y, Zhang Y, Zhu Z Front Neurol. 2024; 15:1449417.

PMID: 39228512 PMC: 11368751. DOI: 10.3389/fneur.2024.1449417.


What You Always Wanted to Know about Endovascular Therapy in Acute Ischemic Stroke but Never Dared to Ask: A Comprehensive Review.

Bucke P, Cohen J, Horvath T, Cimpoca A, Bhogal P, Bazner H Rev Cardiovasc Med. 2024; 23(10):340.

PMID: 39077121 PMC: 11267361. DOI: 10.31083/j.rcm2310340.


Artificial intelligence in ischemic stroke images: current applications and future directions.

Liu Y, Wen Z, Wang Y, Zhong Y, Wang J, Hu Y Front Neurol. 2024; 15:1418060.

PMID: 39050128 PMC: 11266078. DOI: 10.3389/fneur.2024.1418060.


References
1.
Barber P, Darby D, Desmond P, Gerraty R, Yang Q, Li T . Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. Stroke. 1999; 30(10):2059-65. DOI: 10.1161/01.str.30.10.2059. View

2.
Nabavi D, Cenic A, Craen R, Gelb A, Bennett J, Kozak R . CT assessment of cerebral perfusion: experimental validation and initial clinical experience. Radiology. 1999; 213(1):141-9. DOI: 10.1148/radiology.213.1.r99oc03141. View

3.
Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C . Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 282(21):2003-11. DOI: 10.1001/jama.282.21.2003. View

4.
Clark W, Wissman S, Albers G, Jhamandas J, Madden K, Hamilton S . Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999; 282(21):2019-26. DOI: 10.1001/jama.282.21.2019. View

5.
Hoksbergen A, Fulesdi B, Legemate D, Csiba L . Collateral configuration of the circle of Willis: transcranial color-coded duplex ultrasonography and comparison with postmortem anatomy. Stroke. 2000; 31(6):1346-51. DOI: 10.1161/01.str.31.6.1346. View